Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inventors › Christopher D. Benjamin
CB

Christopher D. Benjamin — 17 Patents

BMBiogen Ma: 14 patents #34 of 715Top 5%
PFPurdue Research Foundation: 2 patents #773 of 3,174Top 25%
Beverly, MA: #36 of 490 inventorsTop 8%
Massachusetts: #7,047 of 88,656 inventorsTop 8%
Overall (All Time): #263,971 of 4,157,543Top 7%
17 Patents All Time
Christopher D. Benjamin has been granted 17 US patents. The first was granted in 1993 and the most recent in April 2024. Christopher D. Benjamin ranks #263,971 of 4,157,543 US inventors in our database (top 6.3%). Patent records list Christopher D. Benjamin in Beverly, MA, US.

Patents per Year

Patents granted per year, 1993 to 2024Bar chart with a peak of 4 patents in 2001.peak 41993: 1 patents19931994: 1 patents1999: 1 patents19992001: 4 patents2002: 1 patents20022003: 1 patents2004: 1 patents20042006: 1 patents2008: 2 patents20082011: 1 patents2013: 1 patents20132021: 1 patents2024: 1 patents2024

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11965851 Grid coatings for capture of proteins and other compounds David H. Thompson, Kyle Wright, Scott C. Bolton, Seok-Hee Hyun 2024-04-23 $747,000
10989681 Grid coatings for capture of proteins and other compounds David H. Thompson, Kyle Wright, Scott C. Bolton, Seok-Hee Hyun 2021-04-27
8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders Jeffrey Browning, Paula S. Hochman 2013-06-04
7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling Jeffrey Browning, Paula S. Hochman 2011-05-31
7459537 Anti-lymphotoxin-β receptor antibodies as anti-tumor agents Jeffrey Browning, Werner Meier 2008-12-02
7427403 Methods for inhibiting lymphotoxin β receptor signalling Jeffrey Browning, Paula S. Hochman 2008-09-23
7001598 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents Jeffrey Browning, Werner Meier 2006-02-21
6770745 Common gamma chain blocking agents Linda C. Burkly, Catherine Hession 2004-08-03
6669941 Soluble lymphotoxin-&bgr; receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune disease Jeffrey Browning, Paula S. Hochman 2003-12-30
6403087 Soluble lymphotoxin-&bgr; receptors as therapeutic agents for the treatment of immunological disease Jeffrey Browning, Paula S. Hochman 2002-06-11 $61,324,000
6323027 Common gamma chain monoclonal antibody blocking agents Linda C. Burkly, Catherine Hession, Adrian Whitty 2001-11-27 $95,751,000
6312691 Lymphotoxin-.alpha./.beta. complexes and anti-lympotoxin-.beta. receptor antibodies as anti-tumor agents Jeffrey Browning, Werner Meier 2001-11-06
6307025 VCAM fusion proteins and DNA coding therefor Catherine Hession, Roy Lobb, Susan E. Goelz, Laurelee Osborn, Margaret D. Rosa 2001-10-23 $48,458,000
6252043 Vascular cell adhesion molecule (VCAM) polypeptides Catherine Hession, Roy Lobb, Susan E. Goelz, Laurelee Osborn, Margaret D. Rosa 2001-06-26 $99,245,000
5925351 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease Jeffrey Browning, Paula S. Hochman 1999-07-20 $139,134,000
5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) Catherine Hession, Roy Lobb, Susan E. Goelz, Laurelee Osborn, Margaret D. Rosa 1994-11-22 $21,292,000
5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) Catherine Hession, Roy Lobb, Susan E. Goelz, Laurelee Osborn, Margaret D. Rosa 1993-12-21 $7,286,000

Frequent Collaborators

Jeffrey Browning9 shared
Paula S. Hochman6 shared
Catherine Hession6 shared
Roy Lobb4 shared
Margaret D. Rosa4 shared
Laurelee Osborn4 shared

Nearby-Ranked Inventors

Michael John Caelwaerts17
Umut Zalluhoglu17
Austino Longo17
Till Bredbeck17
Mircea Grigore17
Achim Klein17
Manesh Nadupparambil Sekharan17
Yoshiaki Nishikawa17
Evan Sparks17